Benzinga's Top #PreMarket Losers
December 30, 2013 at 08:23 AM EST
Myriad Genetics (NASDAQ: MYGN ) shares fell 13.01% to $21.00 in the pre-market trading. Myriad Genetics expressed concerns over CMS not valuing BRCA 2 gene in 81211 code, CMS 81211 payment rate. Central European Media Enterprises (NASDAQ: CETV ) dipped 5.84% to $3.55 in the pre-market session. Central
